Primary Care Physician Behaviors in Provision of Information Around Prostate Cancer or Prostate Cancer Screening: 16 Coded Items
Provision of Information | Overall (N=118) % | Control (n=57) % | Intervention (n=61) % |
---|---|---|---|
Discusses incidence or prevalence of prostate cancer | 44 | 46 | 41 |
Discusses risk factors for prostate cancer | 45 | 37 | 53 |
Discusses natural history of prostate cancer | 53 | 51 | 54 |
Discusses mortality of prostate cancer | 61 | 53 | 69 |
Discusses controversies of PCS | 49 | 39 | 60 |
Discusses benefits of PSA testing | 87 | 88 | 87 |
Discusses problems with accuracy of PCS | 91 | 88 | 93 |
Discusses other drawbacks of PSA testinga | 70 | 60 | 80 |
Mentions no screening as an alternativea | 45 | 26 | 63 |
Mentions rectal examination as an alternative | 87 | 93 | 83 |
Discusses benefits of rectal examination | 58 | 63 | 54 |
Discusses drawbacks of rectal examination | 34 | 32 | 36 |
Discusses benefits of watchful waiting/no screening | 31 | 21 | 41 |
Discusses drawbacks of watchful waiting/no screening | 31 | 32 | 30 |
Informs next steps after abnormal PSA test | 78 | 70 | 85 |
Informs next steps after normal PSA test | 24 | 26 | 22 |
PCS=prostate cancer screening; PSA=prostate-specific antigen.
Note: Percentage of physicians who provided information about prostate cancer or prostate cancer screening at least once during an unannounced standardized patient visit.
↵a P <.05.